![Lee Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Lee Smith first degree
Entity | Entity type | Industry | |
---|---|---|---|
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lee Smith via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
SpineVision SA
![]() SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Turenne Capital Partenaires SA
![]() Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Axovan AG
![]() Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Founder | |
Cranfield University | College/University | Masters Business Admin | |
Egalet Ltd.
![]() Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
THERADIAG | Medical Specialties | Director/Board Member | |
MBO+ SAS
![]() MBO+ SAS Investment ManagersFinance Mbo & Co. Sas is an Independent Private Equity firm founded in 2002. Mbo & Co. Sas is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Université Libre de Bruxelles | College/University | Doctorate Degree | |
Ogeda SA
![]() Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Omnes Capital SAS /Venture/
![]() Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Private Equity Investor | |
École Normale Supérieure de Lyon | College/University | Masters Business Admin | |
Université Catholique de Louvain | College/University | Doctorate Degree | |
Henogen SA
![]() Henogen SA Pharmaceuticals: MajorHealth Technology Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Okairos AG
![]() Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
University of Grenoble | College/University | Doctorate Degree | |
Eye Tech Care SA
![]() Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Medical Specialties | Director/Board Member Director/Board Member | |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
European Vaccine Initiative
![]() European Vaccine Initiative BiotechnologyHealth Technology The European Vaccine Initiative manufactures vaccines. The private company is based in London, UK. | Biotechnology | Corporate Officer/Principal | |
ImmuneHealth ASBL
![]() ImmuneHealth ASBL Medical/Nursing ServicesHealth Services develops vaccines to cure disorders of the immune system. Its services include preclinical evaluation, clinical immunomonitoring, technical transfer, consulting and training services, cell, gene, and protein readout development, and clinical biomarker panels validation. The company was founded in 2007 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Director/Board Member | |
Aleva Neurotherapeutics SA
![]() Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland. | Electronic Equipment/Instruments | Director/Board Member | |
Q-Biologicals NV
![]() Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Mestex AG
![]() Mestex AG Pharmaceuticals: MajorHealth Technology Part of Grünenthal Pharma GmbH & Co. KG, Mestex AG is a Swiss pharmaceutical manufacturing company. The company is based in Basel, Switzerland. The CEO of the company is Olivier Valdenaire. Mestex was acquired by Grünenthal GmbH on April 12, 2021. | Pharmaceuticals: Major | Chairman | |
4 for Cells SRL
![]() 4 for Cells SRL Data Processing ServicesTechnology Services 4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011. | Data Processing Services | Director/Board Member | |
Eurobiotech SA | Director/Board Member | ||
MaSTherCell SA
![]() MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
Duke University School of Medicine | College/University | Doctorate Degree | |
ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
Univac NV | Director/Board Member | ||
Thérapixel SA
![]() Thérapixel SA Packaged SoftwareTechnology Services Thérapixel SA designs software publisher for healthcare facilities. The company was founded by Olivier Clatz and Pierre Fillard in 2013 and is headquartered in Valbonne, France. | Packaged Software | Director/Board Member | |
Nouscom AG
![]() Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
PDC Line Pharma SASU
![]() PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member | |
Luciole Medical AG
![]() Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Packaged Software | Chief Executive Officer | |
Themis Bioscience NV
![]() Themis Bioscience NV BiotechnologyHealth Technology Themis Bioscience NV operates as biotechnology company. The firm engages in immunomodulation therapies for infectious diseases. The company is headquartered in Amsterdam, the Netherlands. | Biotechnology | Chief Executive Officer | |
LimmaTech Biologics AG
![]() LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder | |
Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member | |
Adjuvant Capital | Investment Managers | Private Equity Investor | |
GlycoEra AG
![]() GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
LEUKOCARE AG
![]() LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Medical/Nursing Services | Director/Board Member | |
DNAlytics SA
![]() DNAlytics SA Data Processing ServicesTechnology Services DNAlytics SA engages in the development of data-driven precision medicine solutions. The firm provides consultancy services; and academic medical, biological, and clinical research laboratories for the pharmaceutical, biotechnology and In-Vitro Diagnostic companies. It also offers software programs unde rthe REED, LiblineaR, jForest, and BLISS brands. The company was founded by Pierre Dupont and Thibault Helleputte in 2012 and is headquartered in Louvain-la-Neuve, Belgium. | Data Processing Services | Director/Board Member |
Statistics
International
Switzerland | 15 |
Belgium | 15 |
France | 11 |
United Kingdom | 4 |
United States | 3 |
Sectoral
Health Technology | 28 |
Consumer Services | 7 |
Finance | 5 |
Commercial Services | 5 |
Technology Services | 5 |
Operational
Director/Board Member | 82 |
Corporate Officer/Principal | 11 |
Private Equity Investor | 9 |
Independent Dir/Board Member | 7 |
Doctorate Degree | 6 |
Most connected contacts
- Stock Market
- Insiders
- Lee Smith
- Company connections